ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Cong Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5667-5037; OpenAlex author ID A5100331602. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2020: 2 papers

Papers 2

The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.gene.2020.144960 ↗
Citron Rho-Interacting Serine/Threonine Kinase Promotes HIF1a-CypA Signaling and Growth of Human Pancreatic Adenocarcinoma. Co-author DOI 10.1155/2020/9210891 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhile Bai · 2 shared papers, 2020 · strength 0.32
- Paper The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma. DOI 10.1016/j.gene.2020.144960 ↗
- Paper Citron Rho-Interacting Serine/Threonine Kinase Promotes HIF1a-CypA Signaling and Growth of Human Pancreatic Adenocarcin… DOI 10.1155/2020/9210891 ↗
Yong Cheng Ma · 2 shared papers, 2020 · strength 0.32
- Paper The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma. DOI 10.1016/j.gene.2020.144960 ↗
- Paper Citron Rho-Interacting Serine/Threonine Kinase Promotes HIF1a-CypA Signaling and Growth of Human Pancreatic Adenocarcin… DOI 10.1155/2020/9210891 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.